Idexx Laboratories (IDXX) Non-Current Debt (2009 - 2026)

Idexx Laboratories (IDXX) has reported Non-Current Debt for 18 consecutive years, with $299.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Debt fell 33.34% year-over-year to $299.9 million; the TTM figure through Mar 2026 stood at $299.9 million (down 33.34% YoY), while the FY2025 annual figure was $374.8 million, down 16.66% from the prior year.
• Non-Current Debt came in at $299.9 million for Q1 2026 at Idexx Laboratories, down from $374.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $773.4 million in Q1 2022, with the low at $299.9 million in Q1 2026.
• Average Non-Current Debt over 5 years is $570.6 million, with a median of $618.8 million recorded in 2023.
• Across the five-year window, Non-Current Debt slipped 0.69% in 2022 and tumbled 33.34% in 2026, its largest moves.
• Year by year, Non-Current Debt stood at $694.4 million in 2022, then declined by 10.3% to $622.9 million in 2023, then fell by 27.79% to $449.8 million in 2024, then retreated by 16.66% to $374.8 million in 2025, then dropped by 20.01% to $299.9 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $299.9 million, $374.8 million, and $374.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.